Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma

Its importance in long-term survival

G. Zanetta, Gary Keeney, S. S. Cha, Jr Farr G.H., J. A. Katzmann, H. S. Wieand, J. H. Edmonson, K. C. Podratz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to evaluate the importance of deoxyribonucleic acid content to long-term survival from advanced epithelial ovarian carcinoma. STUDY DESIGN: Clinical and pathologic prognostic factors, including deoxyribonucleic acid content measured by means of flow cytometry, were analyzed for 282 patients. RESULTS: In 80% of the patients, the deoxyribonucleic acid patterns were nondiploid. In univariate analysis stage (p < 0.0001), residual disease (p < 0.0001), deoxyribonucleic acid index (p = 0.01), and deoxyribonucleic acid ploidy (p = 0.02) significantly predicted progression-free survival. In multivariate analysis stage (p < 0.001), residual tumor (p = 0.001), deoxyribonucleic acid ploidy (p = 0.02), and deoxyribonucleic acid index (p = 0.02) retained independent prognostic value. Residual disease and deoxyribonucleic acid content retained independent prognostic value for stage III tumors but not for stage IV tumors. CONCLUSION: Deoxyribonucleic acid analysis with flow cytometry provides prognostic information about long-term progression-free survival from advanced ovarian carcinoma and should be considered in the stratification processes of patients in future clinical trials. This prognostic information appears to be inversely related to tumor burden.

Original languageEnglish (US)
Pages (from-to)1217-1225
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume175
Issue number5
StatePublished - 1996

Fingerprint

Carcinoma
Survival
DNA
Ploidies
Disease-Free Survival
Flow Cytometry
Residual Neoplasm
Tumor Burden
Neoplasms
Multivariate Analysis
Clinical Trials

Keywords

  • Deoxyribonucleic acid ploidy
  • ovarian carcinoma
  • prognosis

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Zanetta, G., Keeney, G., Cha, S. S., Farr G.H., J., Katzmann, J. A., Wieand, H. S., ... Podratz, K. C. (1996). Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: Its importance in long-term survival. American Journal of Obstetrics and Gynecology, 175(5), 1217-1225.

Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma : Its importance in long-term survival. / Zanetta, G.; Keeney, Gary; Cha, S. S.; Farr G.H., Jr; Katzmann, J. A.; Wieand, H. S.; Edmonson, J. H.; Podratz, K. C.

In: American Journal of Obstetrics and Gynecology, Vol. 175, No. 5, 1996, p. 1217-1225.

Research output: Contribution to journalArticle

Zanetta, G, Keeney, G, Cha, SS, Farr G.H., J, Katzmann, JA, Wieand, HS, Edmonson, JH & Podratz, KC 1996, 'Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: Its importance in long-term survival', American Journal of Obstetrics and Gynecology, vol. 175, no. 5, pp. 1217-1225.
Zanetta, G. ; Keeney, Gary ; Cha, S. S. ; Farr G.H., Jr ; Katzmann, J. A. ; Wieand, H. S. ; Edmonson, J. H. ; Podratz, K. C. / Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma : Its importance in long-term survival. In: American Journal of Obstetrics and Gynecology. 1996 ; Vol. 175, No. 5. pp. 1217-1225.
@article{070a5ec0a89f47e3b63046d3a71d5633,
title = "Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: Its importance in long-term survival",
abstract = "OBJECTIVE: Our purpose was to evaluate the importance of deoxyribonucleic acid content to long-term survival from advanced epithelial ovarian carcinoma. STUDY DESIGN: Clinical and pathologic prognostic factors, including deoxyribonucleic acid content measured by means of flow cytometry, were analyzed for 282 patients. RESULTS: In 80{\%} of the patients, the deoxyribonucleic acid patterns were nondiploid. In univariate analysis stage (p < 0.0001), residual disease (p < 0.0001), deoxyribonucleic acid index (p = 0.01), and deoxyribonucleic acid ploidy (p = 0.02) significantly predicted progression-free survival. In multivariate analysis stage (p < 0.001), residual tumor (p = 0.001), deoxyribonucleic acid ploidy (p = 0.02), and deoxyribonucleic acid index (p = 0.02) retained independent prognostic value. Residual disease and deoxyribonucleic acid content retained independent prognostic value for stage III tumors but not for stage IV tumors. CONCLUSION: Deoxyribonucleic acid analysis with flow cytometry provides prognostic information about long-term progression-free survival from advanced ovarian carcinoma and should be considered in the stratification processes of patients in future clinical trials. This prognostic information appears to be inversely related to tumor burden.",
keywords = "Deoxyribonucleic acid ploidy, ovarian carcinoma, prognosis",
author = "G. Zanetta and Gary Keeney and Cha, {S. S.} and {Farr G.H.}, Jr and Katzmann, {J. A.} and Wieand, {H. S.} and Edmonson, {J. H.} and Podratz, {K. C.}",
year = "1996",
language = "English (US)",
volume = "175",
pages = "1217--1225",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma

T2 - Its importance in long-term survival

AU - Zanetta, G.

AU - Keeney, Gary

AU - Cha, S. S.

AU - Farr G.H., Jr

AU - Katzmann, J. A.

AU - Wieand, H. S.

AU - Edmonson, J. H.

AU - Podratz, K. C.

PY - 1996

Y1 - 1996

N2 - OBJECTIVE: Our purpose was to evaluate the importance of deoxyribonucleic acid content to long-term survival from advanced epithelial ovarian carcinoma. STUDY DESIGN: Clinical and pathologic prognostic factors, including deoxyribonucleic acid content measured by means of flow cytometry, were analyzed for 282 patients. RESULTS: In 80% of the patients, the deoxyribonucleic acid patterns were nondiploid. In univariate analysis stage (p < 0.0001), residual disease (p < 0.0001), deoxyribonucleic acid index (p = 0.01), and deoxyribonucleic acid ploidy (p = 0.02) significantly predicted progression-free survival. In multivariate analysis stage (p < 0.001), residual tumor (p = 0.001), deoxyribonucleic acid ploidy (p = 0.02), and deoxyribonucleic acid index (p = 0.02) retained independent prognostic value. Residual disease and deoxyribonucleic acid content retained independent prognostic value for stage III tumors but not for stage IV tumors. CONCLUSION: Deoxyribonucleic acid analysis with flow cytometry provides prognostic information about long-term progression-free survival from advanced ovarian carcinoma and should be considered in the stratification processes of patients in future clinical trials. This prognostic information appears to be inversely related to tumor burden.

AB - OBJECTIVE: Our purpose was to evaluate the importance of deoxyribonucleic acid content to long-term survival from advanced epithelial ovarian carcinoma. STUDY DESIGN: Clinical and pathologic prognostic factors, including deoxyribonucleic acid content measured by means of flow cytometry, were analyzed for 282 patients. RESULTS: In 80% of the patients, the deoxyribonucleic acid patterns were nondiploid. In univariate analysis stage (p < 0.0001), residual disease (p < 0.0001), deoxyribonucleic acid index (p = 0.01), and deoxyribonucleic acid ploidy (p = 0.02) significantly predicted progression-free survival. In multivariate analysis stage (p < 0.001), residual tumor (p = 0.001), deoxyribonucleic acid ploidy (p = 0.02), and deoxyribonucleic acid index (p = 0.02) retained independent prognostic value. Residual disease and deoxyribonucleic acid content retained independent prognostic value for stage III tumors but not for stage IV tumors. CONCLUSION: Deoxyribonucleic acid analysis with flow cytometry provides prognostic information about long-term progression-free survival from advanced ovarian carcinoma and should be considered in the stratification processes of patients in future clinical trials. This prognostic information appears to be inversely related to tumor burden.

KW - Deoxyribonucleic acid ploidy

KW - ovarian carcinoma

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=0029860265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029860265&partnerID=8YFLogxK

M3 - Article

VL - 175

SP - 1217

EP - 1225

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -